Transarterial Radioembolization Versus Chemoembolization for Unresectable Large Single Hepatocellular Carcinoma. [PDF]
Lee M +5 more
europepmc +1 more source
Radioimmunotherapy as a targeted strategy of reduced-intensity conditioning for allogeneic transplantation in leukemia. [PDF]
Vo PT, Orozco JJ, Sandmaier BM.
europepmc +1 more source
Personalized dosimetry enhances hepatocellular carcinoma response in Yttrium-90 resin microsphere radioembolization. [PDF]
di Gaeta E +26 more
europepmc +1 more source
Quantitative Contrast-enhanced Ultrasound Evaluation of Hepatocellular Carcinoma Radioembolization. [PDF]
Wessner CE +14 more
europepmc +1 more source
Global landscape of yttrium-90 clinical trials: a systematic registry-based analysis. [PDF]
Ni Q +8 more
europepmc +1 more source
MRI radiomics and <sup>90</sup>Y PET dosimetry for predicting hepatocellular carcinoma response after radioembolization. [PDF]
Huang W +5 more
europepmc +1 more source
Feasibility study of streamlining radioembolization with yttrium-90 resin microspheres without lung shunt fraction measurement for colorectal liver metastasis < 7 cm. [PDF]
Lee M +5 more
europepmc +1 more source
Aspartate Aminotransferase to Platelet Index (APRI) as a Prognostic Factor for Overall Survival After TARE Y90 Resin Microspheres in Primary Liver Cancer Patients: Results from the European, Prospective Observational Study CIRT. [PDF]
Schaefer N +5 more
europepmc +1 more source
Use of yttrium-90 radioembolization to control liver metastases in pancreatic acinar cell carcinoma and pancreatoblastoma: Two case reports. [PDF]
Skorupan N +5 more
europepmc +1 more source
Baseline Hemoglobin Predicts Oncologic Outcomes in Intrahepatic Cholangiocarcinoma Treated With Yttrium-90 Radioembolisation: A Retrospective Cohort Study of 136 Patients. [PDF]
Zahra SA +11 more
europepmc +1 more source

